Skip to main content

Infographic: Building the European biotech sector with world-class talent

What makes European biotech attractive? Talent is one reason. Europe ranks high in the level of innovation and the quality of R&D talent, particularly for research, and the amount of available talent in drug development is increasing. For rare diseases and oncology, however, experienced people are considered to be in short supply. And while the challenges of attracting and retaining biotech talent (as well as talent for business development) are not unique to Europe, these will continue to be important for biotech’s growth in this market. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”
Building the European biotech sector with world-class talent
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com

Related Articles